LOS ANGELES CAPITAL MANAGEMENT LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$204,898
-68.5%
41,227
+63.1%
0.00%
-66.7%
Q3 2021$650,000
-18.3%
25,283
-17.1%
0.00%
-25.0%
Q2 2021$796,000
-32.9%
30,513
-9.2%
0.00%
-20.0%
Q1 2021$1,186,000
+6.3%
33,600
-24.0%
0.01%0.0%
Q4 2020$1,116,000
-34.4%
44,235
-2.0%
0.01%
-37.5%
Q3 2020$1,702,000
-18.1%
45,135
-7.0%
0.01%
-20.0%
Q2 2020$2,079,00048,5550.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders